All session speakers
Track 2: Atopic Dermatitis, Psoriasis and JAK Inhibitors
The Ongoing Debate: JAK Inhibitors vs Monoclonal Antibodies
James Q. Del Rosso, DO
Track 2: Atopic Dermatitis, Psoriasis and JAK Inhibitors
JAK Inhibitors for Atopic Dermatitis/Psoriasis
Linda Stein Gold, MD
Track 2: Atopic Dermatitis, Psoriasis and JAK Inhibitors
Atopic Dermatitis–Non-JAK New Drugs Entering into Dermatology
Leon Kircik, MD
Track 2: Atopic Dermatitis, Psoriasis and JAK Inhibitors
Atopic Dermatitis Therapy Made Easy
Lawrence A. Schachner, MD
Track 2: Atopic Dermatitis, Psoriasis and JAK Inhibitors
Atopic Dermatitis: Where Are We Now?
James Q. Del Rosso, DO
Track 2: Atopic Dermatitis, Psoriasis and JAK Inhibitors